Deck Kelly 4
4 · Inhibrx, Inc. · Filed May 8, 2024
Insider Transaction Report
Form 4
Inhibrx, Inc.INBX
Deck Kelly
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2024-05-06$34.24/sh−17,624$603,446→ 0 totalExercise: $10.52Exp: 2028-11-26→ Common Stock (17,624 underlying) - Exercise/Conversion
Stock Option (right to buy)
2024-05-06$34.24/sh−2,087$71,459→ 0 totalExercise: $11.25Exp: 2030-04-21→ Common Stock (2,087 underlying)
Footnotes (2)
- [F1]Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on November 26, 2019, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
- [F2]Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on April 21, 2021, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.